Search: L773:1932 6203 >
The tyrosine kinase...
-
Hojjat-Farsangi, MohammadKarolinska Institutet
(author)
The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells
- Article/chapterEnglish2013
Publisher, publication year, extent ...
-
2013-10-24
-
Stockholm :Karolinska Institutet, Dept of Oncology-Pathology,2013
-
electronicrdacarrier
Numbers
-
LIBRIS-ID:oai:openarchive.ki.se:10616/41787
-
ISSN:1932-6203
-
10616/41787hdl
-
http://hdl.handle.net/10616/41787URI
-
https://doi.org/10.1371/journal.pone.0078339DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:127646672URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Phosphorylation of receptor tyrosine kinases (RTKs) has a key role in cellular functions contributing to the malignant phenotype of tumor cells. We and others have previously demonstrated that RTK ROR1 is overexpressed in chronic lymphocytic leukemia (CLL). Silencing siRNA downregulated ROR1 and induced apoptosis of CLL cells. In the present study we analysed ROR1 isoforms and the phosphorylation pattern in CLL cells (n=38) applying western blot and flow-cytometry using anti-ROR1 antibodies and an anti-phospho-ROR1 antibody against the TK domain. Two major ROR1 bands with the size of 105 and 130 kDa respectively were identified, presumably representing unglycosylated (immature) and glycosylated (mature) ROR1 respectively as well as a 260 kDa band which may represent dimerized ROR1. A ROR1 band of 64 kDa that may correspond to a C-terminal fragment was also noted, present only in the nucleus. The 105 kDa ROR1 isoform was more frequently expressed in non-progressive as compared to progressive CLL patients (p=0.03). The 64, 105, 130 and 260 kDa bands were constitutively phosphorylated both at tyrosine and serine residues. Phosphorylation intensity of the mature (130 kDa) isoform was significantly higher in progressive than in non-progressive disease (p<0.001). Incubation of CLL cells with a mouse anti-ROR1 KNG or an anti-ROR1 CRD mAb respectively induced dephosphorylation of ROR1 before entering apoptosis. In conclusion CLL cells expressed different isoforms of ROR1 which were constitutively phosphorylated. The mature, phosphorylated ROR1 isoform was associated with a progressive disease stage. Targeting ROR1 by mAbs induced specific dephosphorylation and leukemic cell death. ROR1 might be an interesting therapeutic target.
Added entries (persons, corporate bodies, meetings, titles ...)
-
Khan, Abdul SalamKarolinska Institutet
(author)
-
Daneshmanesh, Amir HosseinKarolinska Institutet
(author)
-
Moshfegh, AliKarolinska Institutet
(author)
-
Sandin, ÅsaKarolinska Institutet
(author)
-
Mansouri, LadanKarolinska Institutet
(author)
-
Palma, MarziaKarolinska Institutet
(author)
-
Lundin, JeanetteKarolinska Institutet
(author)
-
Österborg, AndersKarolinska Institutet
(author)
-
Mellstedt, HåkanKarolinska Institutet
(author)
-
Karolinska Institutet
-
Karolinska Institutet
-
Karolinska Institutet
(creator_code:org_t)
Related titles
-
In:PLOS ONEStockholm : Karolinska Institutet, Dept of Oncology-Pathology1932-6203
Internet link
Find in a library
-
PLOS ONE
(Search for host publication in LIBRIS)
To the university's database
- By the author/editor
-
Hojjat-Farsangi, ...
-
Khan, Abdul Sala ...
-
Daneshmanesh, Am ...
-
Moshfegh, Ali
-
Sandin, Åsa
-
Mansouri, Ladan
-
show more...
-
Palma, Marzia
-
Lundin, Jeanette
-
Österborg, Ander ...
-
Mellstedt, Håkan
-
show less...
- Articles in the publication
-
PLOS ONE
- By the university
-
Karolinska Institutet